Cargando…

Inferring the true number of SARS-CoV-2 infections in Japan

INTRODUCTION: In Japan, as of December 31, 2021, more than 1.73 million laboratory-confirmed cases have been reported. However, the actual number of infections is likely to be under-ascertained due to the epidemiological characteristics such as mild and subclinical infections and limited testing ava...

Descripción completa

Detalles Bibliográficos
Autores principales: McKenzie, Lauren, Shoukat, Affan, Wong, Kai On, Itahashi, Koju, Yasuda, Eiji, Demarsh, Alex, Khan, Kamran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359925/
https://www.ncbi.nlm.nih.gov/pubmed/35961504
http://dx.doi.org/10.1016/j.jiac.2022.08.002
_version_ 1784764239032877056
author McKenzie, Lauren
Shoukat, Affan
Wong, Kai On
Itahashi, Koju
Yasuda, Eiji
Demarsh, Alex
Khan, Kamran
author_facet McKenzie, Lauren
Shoukat, Affan
Wong, Kai On
Itahashi, Koju
Yasuda, Eiji
Demarsh, Alex
Khan, Kamran
author_sort McKenzie, Lauren
collection PubMed
description INTRODUCTION: In Japan, as of December 31, 2021, more than 1.73 million laboratory-confirmed cases have been reported. However, the actual number of infections is likely to be under-ascertained due to the epidemiological characteristics such as mild and subclinical infections and limited testing availability in the early days of the pandemic. In this study, we infer the true number of infections in Japan between January 16, 2020, and December 31, 2021, using a statistical modelling framework that combines data on reported cases and fatalities. METHODS: We used reported COVID-19 deaths and age-specific infection fatality ratios (IFR) to impute the true number of infections. Estimates of IFR were informed from published studies and were adjusted to reflect the effects of pharmaceutical interventions, mass vaccination, and evolving variants. To account for the uncertainty in IFR, we sampled values from relevant distributions. RESULTS: We estimated that as of December 31, 2021, 3.07 million (CrI: 2.05–4.24 million) people had been infected in Japan, which is 1.77 times higher than the 1.73 million reported cases. Our meta-analysis confirmed that these findings were consistent with the intermittent seroprevalence studies conducted in Japan. CONCLUSIONS: We have estimated that a substantial number of COVID-19 infections in Japan were unreported, particularly in adults. Our approach provides a more realistic assessment of the true underlying burden of COVID-19. The results of this study can be used as fundamental components to strengthen population health control and surveillance measures.
format Online
Article
Text
id pubmed-9359925
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-93599252022-08-09 Inferring the true number of SARS-CoV-2 infections in Japan McKenzie, Lauren Shoukat, Affan Wong, Kai On Itahashi, Koju Yasuda, Eiji Demarsh, Alex Khan, Kamran J Infect Chemother Original Article INTRODUCTION: In Japan, as of December 31, 2021, more than 1.73 million laboratory-confirmed cases have been reported. However, the actual number of infections is likely to be under-ascertained due to the epidemiological characteristics such as mild and subclinical infections and limited testing availability in the early days of the pandemic. In this study, we infer the true number of infections in Japan between January 16, 2020, and December 31, 2021, using a statistical modelling framework that combines data on reported cases and fatalities. METHODS: We used reported COVID-19 deaths and age-specific infection fatality ratios (IFR) to impute the true number of infections. Estimates of IFR were informed from published studies and were adjusted to reflect the effects of pharmaceutical interventions, mass vaccination, and evolving variants. To account for the uncertainty in IFR, we sampled values from relevant distributions. RESULTS: We estimated that as of December 31, 2021, 3.07 million (CrI: 2.05–4.24 million) people had been infected in Japan, which is 1.77 times higher than the 1.73 million reported cases. Our meta-analysis confirmed that these findings were consistent with the intermittent seroprevalence studies conducted in Japan. CONCLUSIONS: We have estimated that a substantial number of COVID-19 infections in Japan were unreported, particularly in adults. Our approach provides a more realistic assessment of the true underlying burden of COVID-19. The results of this study can be used as fundamental components to strengthen population health control and surveillance measures. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022-11 2022-08-09 /pmc/articles/PMC9359925/ /pubmed/35961504 http://dx.doi.org/10.1016/j.jiac.2022.08.002 Text en © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
McKenzie, Lauren
Shoukat, Affan
Wong, Kai On
Itahashi, Koju
Yasuda, Eiji
Demarsh, Alex
Khan, Kamran
Inferring the true number of SARS-CoV-2 infections in Japan
title Inferring the true number of SARS-CoV-2 infections in Japan
title_full Inferring the true number of SARS-CoV-2 infections in Japan
title_fullStr Inferring the true number of SARS-CoV-2 infections in Japan
title_full_unstemmed Inferring the true number of SARS-CoV-2 infections in Japan
title_short Inferring the true number of SARS-CoV-2 infections in Japan
title_sort inferring the true number of sars-cov-2 infections in japan
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359925/
https://www.ncbi.nlm.nih.gov/pubmed/35961504
http://dx.doi.org/10.1016/j.jiac.2022.08.002
work_keys_str_mv AT mckenzielauren inferringthetruenumberofsarscov2infectionsinjapan
AT shoukataffan inferringthetruenumberofsarscov2infectionsinjapan
AT wongkaion inferringthetruenumberofsarscov2infectionsinjapan
AT itahashikoju inferringthetruenumberofsarscov2infectionsinjapan
AT yasudaeiji inferringthetruenumberofsarscov2infectionsinjapan
AT demarshalex inferringthetruenumberofsarscov2infectionsinjapan
AT khankamran inferringthetruenumberofsarscov2infectionsinjapan